Market News
Stay updated with the latest market trends, earnings, and economic indicators.
mRNA vaccines protect against severe infectious diseases, review confirms
Billions of mRNA vaccine doses administered globally confirm their safety and effectiveness against infectious diseases, including severe COVID-19, across all age groups and health conditions. Researchers emphasize that serious side effects are rare, with benefits far outweighing risks. This technology, now proven, holds immense promise for future vaccines and personalized treatments, though equitable global access remains crucial.
BSE 500 stocks: Adani Ports, Marico, Ather, Piramal Finance hit new highs
Adani Enterprises, Aurobindo Pharma, GMR Airports, Gujarat Flurochemicals, Oracle Financial Services and Star Health Insurance from BSE 500 stocks registered 52-week highs on Wednesday.
Motilal Oswal sector of the week: Healthcare; Max, Global Health top picks
Indian healthcare sector remains well positioned for sustained long-term growth, supported by structural demand, expanding hospital infra, higher healthcare spends, and favourable demographic trends.
Top Five Reasons Health Insurance Claims Are Rejected: All That Policyholder Should Know
Some health insurance policies may appear attractive because they are available at a lower premium.
Fluence deal signals Honasa’s pivot towards health-beauty convergence
As beauty consumers increasingly demand science-backed and holistic solutions, Honasa is blurring the lines between cosmetics, wellness and healthcare, with nutraceuticals emerging as a new battleground for growth and differentiation.
Aarogya Setu 2.0 Launch Today: Health Minister Nadda To Unveil Revamped Digital App With More Features
Nadda is expected to launch the app in addition to a series of other health initiatives at 2 p.m. on Monday in New Delhi.
Niva Bupa, Star Health Get Buy Calls As Nomura Initiates On Four Insurers -- Check Target Prices
Nomura initiated coverage on India's non-life insurance sector with Buy ratings on Niva Bupa and Star Health, while assigning Neutral ratings to ICICI Lombard and PB Fintech amid regulatory uncertainty.
1,000 Dead And Counting: How Record-Breaking Heatwave Is Becoming Public Health Crisis In France
Slovakia, Serbia, Croatia, Italy, Austria and western Ukraine were also affected.
India’s nutraceutical market set to nearly double to $57 billion by 2030 on preventive health boom
India's health-conscious population is fueling a boom in the nutraceutical market, projected to nearly double to $55-57 billion by 2030. This shift towards preventive care, supported by e-commerce and government initiatives, sees the sector growing at an impressive 10.5% CAGR. While regulatory efforts are strengthening, challenges like consumer awareness and scientific validation persist, yet the industry is poised for significant expansion.
Markets ahead: West Asia tensions, crude prices key factors to watch out
Developments on the geopolitical front, with the latest military exchanges involving the US and Iran, their impact on crude oil prices and domestic macroeconomic data announcements would dictate sentiments in the stock market this week, analysts said. Besides, trading patterns of foreign investors and progress of the southwest monsoon would also remain the key areas of focus for investors, they added. "Market participants will closely monitor Industrial Production (IIP) data, the final HSBC Manufacturing, Services and Composite PMI readings, and the foreign exchange reserves data for fresh insights into the health of the domestic economy," Ajit Mishra, SVP, Research, Religare Broking Ltd, said. Globally, the trajectory of crude oil prices and geopolitical developments in West Asia will remain key drivers of market sentiment, he said. The monthly auto sales numbers on July 1 will also be tracked by investors closely. "The week ahead is likely to be shaped by developments on the ..
Health ministry proposes faster approvals for medical device manufacturing licences
The Union health ministry is proposing to significantly cut down the time taken to issue manufacturing licenses for medical devices. Aimed at boosting ease of doing business and ensuring quicker access to quality products, the amendments will reduce timelines for low to high-risk devices. For instance, Class B devices will see a reduction from 140 to 115 days, and high-risk Class C and D devices from 105 to 90 days.
Youthful Leadership, Strategic Vision: Chirag Pan at the Helm of PAN Health
Chirag Pan, CEO & MD of PAN Health